166 results on '"Le Cam-Duchez, Véronique"'
Search Results
2. Exacerbation of thromboinflammation by JAK2V617F mutation worsens the prognosis of cerebral venous sinus thrombosis
3. Is there a role for the laboratory monitoring in the management of specific antidotes of direct oral anticoagulants?
4. Factor XII deficiency evaluated by thrombin generation assay
5. Evaluation of thrombin generation assay in factor XI deficiency
6. Hemorrhagic disseminated intravascular coagulation after 177Lu-Dotatate in metastatic midgut neuroendocrine tumor: A case report
7. Heterozygous large deletion mimicking homozygous substitution in MCFD2 in a patient with combined Factor V and Factor VIII deficiency.
8. Is citrate theophylline adenosine dipyridamole (CTAD) better than citrate to survey unfractionated heparin treatment? Has delayed centrifugation a real impact on this survey?
9. Thrombin generation profile in non-thrombotic factor V Leiden carriers
10. Stability over time of immature platelet fraction and comparison between EDTA and citrated whole blood samples
11. C-reactive protein and D-dimer in cerebral vein thrombosis: Relation to clinical and imaging characteristics as well as outcomes in a French cohort study
12. Thrombin generation test as a marker for high risk venous thrombosis pregnancies
13. Investigation of thrombin generation assay to predict vaso-occlusive crisis in adulthood with sickle cell disease
14. Anticoagulation Monitoring with Activated Partial ThromboPlastin Time and Anti-Xa Activity in Intensive Care Unit Patients: Interest of Thrombin Generation Assay
15. Postmortem delay and stress/hypoxia markers in the sudden infant death syndrome (SIDS)
16. Management of dabigatran after overdosage: two case reports and suggestions for monitoring
17. Comparison of markers of coagulation activation and thrombin generation test in uncomplicated pregnancies
18. Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls
19. Assessment of Reticulocyte and Erythrocyte Parameters From Automated Blood Counts in Vaso-Occlusive Crisis on Sickle Cell Disease
20. Cerebral Venous Thrombosis: Clinical, Radiological, Biological, and Etiological Characteristics of a French Prospective Cohort (FPCCVT)—Comparison With ISCVT Cohort
21. First observation of inhibitor development against efmoroctocog alfa in France
22. Afibrinogenemia with two compound heterozygous mutations in FGA gene
23. Hypercoagulability Evaluation in Antiphospholipid Syndrome without Anticoagulation Treatment with Thrombin Generation Assay: A Preliminary Study
24. Investigation of Coagulation Biomarkers to Assess Clinical Deterioration in SARS-CoV-2 Infection
25. Role of Toll-like Receptors 2 and 4 in Mediating Endothelial Dysfunction and Arterial Remodeling in Primary Arterial Antiphospholipid Syndrome
26. Acquired factor XIII deficiency in a child with pure erythroid leukemia
27. Dabigatran Level Before Reversal Can Predict Hemostatic Effectiveness of Idarucizumab in a Real-World Setting
28. Theophylline adenosine dipyridamole (CTAD) and citrate evaluation to survey unfractionated heparin treatment: a delayed centrifugation validation for anti-Xa measurement?
29. Factor VIII assays in treated hemophilia A patients
30. Influence of three potential genetic risk factors for thrombosis in 43 families carrying the factor V Arg 506 to Gln mutation
31. Hydroxychloroquine reverses the prothrombotic state in a mouse model of antiphospholipid syndrome: Role of reduced inflammation and endothelial dysfunction
32. Factor VIII and IX assays for post‐infusion monitoring in hemophilia patients: Guidelines from the French BIMHO group (GFHT).
33. Évaluation du citrate théophylline adénosine dipyridamole (CTAD) et du citrate comme anticoagulant dans la surveillance du traitement par héparine non fractionnée : validation d'une centrifugation différée pour le dosage de l'anti-Xa
34. Anti-Xa Oral Anticoagulant Plasma Concentration Assay in Real Life: Rivaroxaban and Apixaban Quantification in Emergency With LMWH Calibrator
35. Development of a thrombin generation test in cultured endothelial cells: Evaluation of the prothrombotic effects of antiphospholipid antibodies
36. Acquired hemophilia possibly induced by etanercept in a patient with rheumatoid arthritis
37. Evaluation of dabigatran, rivaroxaban and apixaban target-specific assays in a multicenter French study
38. Adjusted value of thromboprophylaxis in hospitalized obese patients: A comparative study of two regimens of enoxaparin: The ITOHENOX study
39. Un cas d’hémophilie acquise possiblement induit par l’étanercept dans la polyarthrite rhumatoïde
40. Multicentre evaluation of CK Prest® for assaying plasma levels of factor IX fused with albumin (Idelvion®).
41. Anti-Xa Oral Anticoagulant Plasma Concentration Assay in Real Life: Rivaroxaban and Apixaban Quantification in Emergency With LMWH Calibrator.
42. Exacerbation of thrombo-inflammation by JAK2V617Fmutation worsens the prognosis of cerebral venous sinus thrombosis
43. Erythropoietin and renin as biological markers in critically ill patients
44. Thrombin generation test as a marker for high risk venous thrombosis pregnancies.
45. Large external quality assessment survey on thrombin generation with CAT: further evidence for the usefulness of normalisation with an external reference plasma
46. Algorithms using clinical and genetic data (CYP2C9, VKORC1) are relevant to predict warfarin dose in patients with different INR targets
47. Comparison between the centrifugation on MPA C10 (Roche Diagnostics) and the centrifugation according recommendations of GEHT (Groupe d’étude de l’hémostase et de la thrombose) for the daily hemostasis assays
48. Factor V Leiden Homozygous Genotype and Pregnancy Outcomes
49. Rare genotypes of protein Z gene are a risk factor for premature myocardial infarction but not protein Z plasma level
50. Factor V Cambridge mutation and activated protein C resistance assays
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.